Search results for:
OXcarbazepine
OXcarbazepine
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| OXcarbazepine |
SUSPENSION, ORAL |
60 mg/mL (250 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| OXcarbazepine |
TABLET, ORAL |
150 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| OXcarbazepine |
TABLET, ORAL |
300 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Sep. 29, 2023
UNC Health
Caution – Category 2: Non-antineoplastic Hazardous Medication, see below for exposure mitigation strategies
Therapeutic Interchange
Non-Formulary Order
Formulary Equivalent Order
OXcarbazepine Tablet, ER (24 hr)
OXcarbazepine Tablet, IR
150 mg once daily
75 mg twice daily
300 mg once daily
150 mg twice daily
600 mg once daily
300 mg twice daily
1200 mg once daily
600 mg twice daily
2400 mg once daily
1200 mg twice daily